Based on published phase 2 clinical trial data, the most commonly reported adverse effects include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and reduced appetite are the most frequently reported side effects
Meanwhile, among the current market leaders, Novo screens as the most attractive from a valuation and ESG risk perspective
Book Now Boost natural growth hormone production with our premium 10/10 mg CJC-1295 and Ipamorelin blend
Patients with severe kidney disease, a history of severe gastrointestinal disease, or significant liver impairment should discuss the risks carefully with their prescriber before starting any tirzepatide product
If youre struggling to manage your weight and diet, and exercise hasnt been effective, youre not alone